ValenTx Raises $22 Million
ValenTx Inc., a Carpenteria, Calif.-based developer of an implantable medical device to address morbid obesity, has raised $22 million in Series B funding. SV Life Sciences led the round, and was joined by Covidient Ventures and return backers Sapient Capital, EDF Ventures, Kaiser Permanente Ventures, Affinity Capital Partners and TGap Ventures.
5 January 2010•2 mins read
